Semaglutide: Next Generation for Weight Loss
Semaglutide is a glucagon-like peptide (GLP-1) analog. GLP-1 is a peptide hormone produced in the small intestine that stimulates insulin secretion and inhibits glucagon secretion, slows gastric emptying, and regulates appetite – all of which aid in healthy and effective weight loss. Studies by The New England Journal of Medicine and Journal of American Medical Association have shown that Semaglutide can reduce appetite, regulate glucose levels, and reduce food cravings that have resulted in a 15% loss of total body weight.
Semaglutide is not a stimulant; it is a non-habit forming, clinically-proven effective peptide for long-term results. It works on the same receptors as powerful, naturally-occurring GLP-1 hormones that exist in your body, which improve your metabolic function, and regulate your digestion so you can feel full longer.. GLP-1s also have powerful benefits including reducing inflammation and risk of cardiovascular disease to help you not only lose weight, but also live a longer and healthier life.
This peptide, often referred to as an incretin mimetic, mimics the functions of the incretin hormones, which are naturally released by the pancreas while eating. Incretin hormones include insulin, key to how the body uses food, and glucagon-a hormone, which helps release stored sugar into the bloodstream.
There is evidence that GLP-1 agonists may help people who are obese lose weight by signaling the brain to eat less, and slowing gastric emptying, which results in a prolonged feeling of fullness.